VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, John C. Bell, Naomi De Silva et al.|Cancer Cell|2015Cited by 104
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell VaccineChantal G. Lemay, Rebecca C. Auer, Julia L. Rintoul et al.|Molecular Therapy|2012Cited by 93
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Jean‐Simon Diallo, Cory Batenchuk et al.|Nature Communications|2015Cited by 69
Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic LeukemiaDavid P. Conrad, Harold Atkins, Jovian Tsang et al.|Clinical Cancer Research|2013Cited by 35